U.S. Markets close in 24 mins
  • S&P 500

    3,231.72
    -5.20 (-0.16%)
     
  • Nasdaq

    10,612.82
    -20.17 (-0.19%)
     
  • Russell 2000

    1,449.26
    -2.20 (-0.15%)
     
  • Crude Oil

    40.13
    +0.20 (+0.50%)
     
  • Gold

    1,865.60
    -2.80 (-0.15%)
     
  • Silver

    23.00
    -0.10 (-0.43%)
     
  • EUR/USD

    1.1669
    +0.0007 (+0.0583%)
     
  • 10-Yr Bond

    0.6660
    -0.0100 (-1.48%)
     
  • Vix

    29.37
    +0.79 (+2.76%)
     
  • GBP/USD

    1.2738
    +0.0012 (+0.0968%)
     
  • BTC-USD

    10,635.08
    +385.61 (+3.76%)
     
  • CMC Crypto 200

    216.53
    +7.59 (+3.63%)
     
  • FTSE 100

    5,822.78
    -76.48 (-1.30%)
     
  • Nikkei 225

    23,087.82
    -258.67 (-1.11%)
     

Earnings Outlook for Meridian Bioscience

Benzinga Insights

On Friday, August 07, Meridian Bioscience (NASDAQ: VIVO) will release its latest earnings report. Check out Benzinga's preview to understand the implications.

Earnings and Revenue

Based on Meridian Bioscience management projections, analysts predict EPS of $0.25 on revenue of $66.04 million. In the same quarter last year, Meridian Bioscience announced EPS of $0.16 on revenue of $48.44 million. If the company were to post earnings in-line with the consensus estimate when it reports Friday, EPS would be up 56.25%. Here's how the company's reported EPS has compared to analyst estimates in the past:

Quarter

Q2 2020

Q1 2020

Q4 2019

Q3 2019

EPS Estimate

0.08

0.07

0.09

0.09

EPS Actual

0.23

0.10

0.13

0.16

Revenue Estimate

49.26 M

48.90 M

50.59 M

49.81 M

Revenue Actual

57.30 M

47.42 M

50.85 M

48.44 M

Stock Performance

Over the last 52-week period, shares are up 117.93%. Given that these returns are generally positive, long-term shareholders should be content going into this earnings release.

View more earnings on VIVO

Don't be surprised to see the stock move on comments made during its conference call. Meridian Bioscience is scheduled to hold the call at 10:00:00 ET and can be accessed here: https://investor.meridianbioscience.com/events/event-details/q3-2020-financial-results-conference-call

See more from Benzinga

© 2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.